{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:58:20Z","timestamp":1770962300148,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1097\/jcp.0b013e318160738e","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T06:33:54Z","timestamp":1236234834000},"page":"32-38","source":"Crossref","is-referenced-by-count":46,"title":["Safety and Tolerability of Duloxetine at 60 mg Once Daily in Elderly Patients With Major Depressive Disorder"],"prefix":"10.1097","volume":"28","author":[{"given":"Joel","family":"Raskin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis G.","family":"Wiltse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Dinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durisala","family":"Desaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius","family":"Katona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1176\/ajp.153.8.1001","article-title":"Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study.","volume":"153","author":"Conwell","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archpsyc.57.6.601","article-title":"Prevalence of depression and its treatment in an elderly population: the Cache County study.","volume":"57","author":"Steffens","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/jama.1992.03490080092032","article-title":"Diagnosis and treatment of depression in late life.","volume":"268","year":"1992","journal-title":"JAMA"},{"issue":"suppl 5","key":"R4-6-20210128","first-page":"5","article-title":"The diagnosis and treatment of late-life depression.","volume":"57","author":"Rothschild","year":"1996","journal-title":"J Clin Psychiatry"},{"issue":"suppl 20","key":"R5-6-20210128","first-page":"4","article-title":"Adverse reactions of antidepressants in elderly patients.","volume":"60","author":"Pollock","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"suppl 5","key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/00004850-199809005-00008","article-title":"Care of depression in the elderly: comparative pharmacokinetics of SSRIs.","volume":"13","author":"Baumann","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-2001-14281","article-title":"Risk profile of SSrIs in elderly depressive patients with co-morbid physical illness.","volume":"34","author":"Kurzthaler","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.157.3.360","article-title":"Use of antidepressants among elderly subjects: trends and contributing factors.","volume":"157","author":"Mamdani","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"suppl 5","key":"R9-6-20210128","first-page":"12","article-title":"Use of serotonin selective reuptake inhibitors in geriatric depression.","volume":"57","author":"Newhouse","year":"1996","journal-title":"J Clin Psychiatry"},{"issue":"suppl 4","key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004850-199206004-00013","article-title":"Paroxetine: an overview of dosage, tolerability, and safety.","volume":"6","author":"Jenner","year":"1992","journal-title":"Int Clin Psychopharmacol"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S1041610201007487","article-title":"Retrospective review of selective serotonin reuptake inhibitors and falling in older nursing home residents.","volume":"13","author":"Arfken","year":"2001","journal-title":"Int Psychogeriatr"},{"key":"R12-6-20210128","first-page":"5233","article-title":"Synthesis and biological activity of some known and putative duloxetine metabolites. Bioorg Med Chem Lett. 2004;14:3481-3486.","volume":"14","author":"Kuo","year":"2004","journal-title":"Erratum in: Bioorg Med Chen Lett"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO;2-9","article-title":"Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis.","volume":"6","author":"Steffens","year":"1997","journal-title":"Depress Anxiety"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","article-title":"Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.","volume":"178","author":"Thase","year":"2001","journal-title":"Br J Psychiatry"},{"key":"R15-6-20210128","first-page":"13","article-title":"Cardiovascular effects of antidepressant drugs: updated.","volume":"59","author":"Glassman","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4088\/JCP.v59n1002","article-title":"Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients.","volume":"59","author":"Thase","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","article-title":"Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.","volume":"25","author":"Bymaster","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-3956(02)00060-2","article-title":"Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.","volume":"36","author":"Detke","year":"2002","journal-title":"J Psychiatr Res"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4088\/JCP.v63n0309","article-title":"Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.","volume":"63","author":"Goldstein","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.jcp.0000132448.65972.d9","article-title":"Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.","volume":"24","author":"Goldstein","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R21-6-20210128","first-page":"106","article-title":"Duloxetine for the treatment of major depressive disorder.","volume":"36","author":"Nemeroff","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2318-4-11","article-title":"Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: an open-label study.","volume":"4","author":"Wohlreich","year":"2004","journal-title":"BMC Geriatr"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.2007.164.6.900","article-title":"Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.","volume":"164","author":"Raskin","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.jcp.0000155815.44338.95","article-title":"Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine.","volume":"25","author":"Thase","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00002018-200730050-00007","article-title":"An evaluation of the cardiovascular safety profile of duloxetine.","volume":"30","author":"Wernicke","year":"2007","journal-title":"Drug Saf"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/FJC.0b013e318030aff7","article-title":"QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.","volume":"49","author":"Zhang","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report.","volume":"17","author":"Yesavage","year":"1982","journal-title":"J Psychiatr Res"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R30-6-20210128","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-0327(97)00107-9","article-title":"The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis.","volume":"46","author":"Mittmann","year":"1997","journal-title":"J Affect Disord"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1176\/appi.ajp.157.5.729","article-title":"Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life.","volume":"157","author":"Bondareff","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R33-6-20210128","first-page":"57","article-title":"Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.","volume":"53","author":"Dunner","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1185\/030079906X162719","article-title":"A retrospective pooled analysis of duloxetine safety in 23983 subjects.","volume":"23","author":"Gahimer","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.279.4.287","article-title":"Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.","volume":"279","author":"Roose","year":"1998","journal-title":"JAMA"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/01.JGP.0000204328.50105.b3","article-title":"Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.","volume":"14","author":"Johnson","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJM199809243391303","article-title":"Antidepressants and the risk of falls among nursing home residents.","volume":"339","author":"Thapa","year":"1998","journal-title":"N Engl J Med"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4088\/PCC.v08n0503","article-title":"Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical trials.","volume":"8","author":"Wise","year":"2006","journal-title":"Prim Care Companion J Clin Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200802000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:36:54Z","timestamp":1618277814000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200802000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318160738e","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}